Bovine colostrum
Bovine colostrum is the secretion produced by the cow in the first hours/days after calving, rich in immunoglobulins, lactoferrin, growth factors, and antimicrobial peptides. As a supplement, it is used mainly to modulate intestinal barrier function and some aspects of mucosal immunity. Clinical evidence is heterogeneous and depends on product quality, dose, population, and the outcomes measured.
Bioactive fraction of first milk: support for the intestinal barrier and mucosal defenses
Bovine colostrum is the secretion produced by cows in the first hours/days after calving, rich in immunoglobulins, lactoferrin, growth factors, and antimicrobial peptides. As a supplement, it is used primarily to modulate intestinal barrier function and certain aspects of mucosal immunity. Clinical evidence is heterogeneous and depends on product quality, dose, population, and the outcomes measured.
Mechanism of action
The proposed mechanisms include: (1) local action in the intestinal lumen with binding/neutralization of pathogens and toxins (immunoglobulins, lactoferrin); (2) modulation of the microbial ecosystem and bacterial adhesion (lactoferrin, oligosaccharides); (3) support of the epithelial barrier and tight junctions and reduction of permeability induced by stress/exercise/inflammation (growth factors and bioactive peptides); (4) modulation of mucosal immunity (e.g. secretory IgA indirectly, cytokines) and the local inflammatory response. Systemic absorption of intact proteins in adults is limited; therefore, many of the expected effects are primarily gastrointestinal and immune-related at the mucosal level.
Supported benefits
- Reduction of markers of increased intestinal permeability and/or enterocyte damage in specific contexts (e.g. intense exercise stress, certain models of intestinal insult) (moderate)
- Reduction in the duration or severity of some episodes of infectious diarrhea in specific populations and contexts (variable evidence by pathogen and setting) (moderate)
- Possible reduction in the incidence or duration of upper respiratory tract infections in some groups (e.g. athletes), with results that are not always consistent (limited)
- Improvement of nonspecific gastrointestinal symptoms in some individuals (e.g. discomfort, bowel habits), with high heterogeneity and risk of bias (emerging)
Safety & side effects
- Gastrointestinal disturbances (nausea, cramps, bloating, diarrhea, or constipation), especially at higher doses
- Reactions in individuals with sensitivity to dairy products (not necessarily IgE-mediated allergy)
- Rare: allergic reactions in individuals with milk protein allergy (potentially severe as well)
FAQ
Does bovine colostrum “boost” the immune system?
More accurately, it may modulate certain functions of mucosal immunity and the intestinal barrier. Clinical effects (e.g. respiratory infections) are variable and depend on population, dose, duration, and product quality.
Does it contain lactose? Is it suitable for people who are intolerant?
It may contain lactose in variable amounts. Lactose intolerance is different from milk protein allergy: people who are intolerant may experience gastrointestinal symptoms, while those who are allergic may have even severe reactions. Tolerability should be assessed on a case-by-case basis.
Do the growth factors (e.g. IGF-1) in colostrum have systemic effects?
In adults, absorption of intact proteins is limited; many effects are considered local at the intestinal level. However, composition varies between products, and it is not possible to generalize biologically active exposure without specific formulation data and dedicated studies.
Is it useful for “intestinal permeability”?
Some studies show improvements in markers of permeability or intestinal damage in specific contexts (e.g. exercise stress). It is not universal proof for all gastrointestinal conditions and does not replace clinical evaluation of the causes.
How much does product quality matter?
A great deal: processing can denature proteins and reduce biological activity; moreover, controls for contaminants and microbial load are important. Standardization (e.g. IgG) and traceability are key elements for interpreting the plausibility of the effects.
The information provided is for informational and educational purposes only. It does not constitute medical advice. Use must be evaluated and authorized by a qualified healthcare professional.
Mechanism of action
The proposed mechanisms include: (1) local action in the intestinal lumen with binding/neutralization of pathogens and toxins (immunoglobulins, lactoferrin); (2) modulation of the microbial ecosystem and bacterial adhesion (lactoferrin, oligosaccharides); (3) support of the epithelial barrier and tight junctions and reduction of permeability induced by stress/exercise/inflammation (growth factors and bioactive peptides); (4) modulation of mucosal immunity (e.g. secretory IgA indirectly, cytokines) and of the local inflammatory response. Systemic absorption of intact proteins in adults is limited; therefore many of the expected effects are mainly gastrointestinal and immune-related at the mucosal level.
Scientific benefits
Contraindications
- Allergy to cow’s milk proteins (relevant contraindication due to the risk of allergic reactions)
- History of anaphylaxis or severe reactions to dairy products
- Conditions in which the introduction of milk-derived products is discouraged by the clinician (e.g. some therapeutic diets or specific gastrointestinal diseases in the acute phase)
Side effects
- Gastrointestinal disturbances (nausea, cramps, bloating, diarrhea or constipation), especially at higher doses
- Reactions in individuals with sensitivity to dairy products (not necessarily an IgE-mediated allergy)
- Rare: allergic reactions in individuals with milk protein allergy (potentially also severe)
Interactions
- Immunosuppressive therapies or autoimmune conditions: possible theoretical interference with immunomodulatory goals; requires individual clinical evaluation
- Antibiotics: this is not a typical pharmacokinetic interaction, but changes in the microbiota may modify the overall gastrointestinal response
- Iron supplements: lactoferrin binds iron; the clinical impact on iron absorption from supplements is uncertain and may depend on formulation and timing
Regulatory status
In the EU and in many countries it is sold as a dietary supplement; health claims are regulated and often limited. It is not a drug. The composition may not be uniformly standardized across brands; any quality certifications (e.g. contaminant testing, GMP, certifications for sport) depend on the manufacturer.
Supplements and peptides
Gut and Immune SystemEchinacea
The name “echinacea” mainly refers to Echinacea purpurea, Echinacea angustifolia, and Echinacea pallida. The extracts…
Gut and Immune SystemLactoferrin
Lactoferrin (LF) is a glycoprotein of the transferrin family, present in mucosal secretions (milk, saliva, tears) and…
Gut and Immune SystemMulti-strain probiotics
Multi-strain probiotics are formulations that combine multiple species and/or strains (e.g. Lactobacillus,…